Trulieve (OTCQX: TCNNF) CFO receives new options and RSU grants

Rhea-AI Filing Summary

Trulieve Cannabis Corp. Chief Financial Officer Jan Reese reported receiving new equity compensation awards. Reese was granted options to buy 41,668 subordinate voting shares at an exercise price of $6.4000 per share, expiring on March 13, 2033. These options vest in three equal annual installments on December 1, 2026, December 1, 2027, and December 1, 2028, and 41,668 options are shown as held after the grant. Reese also received 58,594 restricted stock units, each representing one subordinate voting share. According to the award terms, 50% of these RSUs vest on December 1, 2027 and the remaining 50% vest on December 1, 2028, with 58,594 shares reported as held following this grant. These are compensation-related acquisitions, not open‑market purchases or sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reese Jan

(Last) (First) (Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE FL 32312

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Subordinate Voting Shares	03/13/2026		A		58,594(1)	A	$0	58,594	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.4	03/13/2026		A		41,668		(2)	03/13/2033	Subordinate Voting Shares	41,668	$0	41,668	D

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028.

2. The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Trulieve (TCNNF) CFO Jan Reese receive?

Trulieve CFO Jan Reese received 41,668 stock options and 58,594 restricted stock units as compensation. The options have a set exercise price and long-term vesting, while the RSUs convert into subordinate voting shares as vesting conditions are met.

What are the terms of Jan Reese’s new stock options at Trulieve (TCNNF)?

Jan Reese’s award includes options for 41,668 subordinate voting shares at an exercise price of $6.4000 per share. These options vest in three equal annual installments and expire on March 13, 2033, aligning incentives with multi-year company performance.

How do the RSUs granted to Trulieve (TCNNF) CFO vest?

The 58,594 RSUs granted to Trulieve’s CFO vest in two stages. Half vest on December 1, 2027, and the remaining half on December 1, 2028, encouraging longer-term retention and alignment with shareholder interests over that period.

Were Jan Reese’s Trulieve (TCNNF) equity awards open-market share purchases?

No, the reported transactions are compensation-related grants, not open-market purchases. Both the stock options and RSUs were acquired at a transaction price of $0.00, reflecting awards granted by the company rather than shares bought on the market.

How many Trulieve (TCNNF) shares does the CFO hold after these grants?

Following these awards, Jan Reese is reported holding 41,668 stock options and 58,594 subordinate voting shares tied to RSUs. These figures reflect the positions after the March 13, 2026 grant transactions disclosed in the insider filing.